Falhammar Henrik, Kjellman Magnus, Calissendorff Jan
Department of EndocrinologyMetabolism and Diabetes, Karolinska University Hospital, Stockholm, Sweden.
Department of Molecular Medicine and SurgeryKarolinska Institutet, Stockholm, Sweden.
Endocr Connect. 2018 Jan;7(1):186-192. doi: 10.1530/EC-17-0321. Epub 2017 Dec 7.
With the increasing access to imaging more pheochromocytomas are diagnosed in the workup of adrenal incidentalomas. This may have changed the occurrence of the classic presentation with hypertension and the classic triad (headaches, sweating and palpitation).
We reviewed 94 consecutive cases of pheochromocytomas. Two cases of ectopic ACTH-syndrome were subsequently excluded.
Of the 92 cases included 64% had presented as an incidentaloma, 32% as a suspected pheochromocytoma and 4% had been screened because of previously diagnosed MEN2A. Those screened were youngest while those with incidentalomas were oldest. The females were more common in the incidentaloma and the screening groups, and males in the suspected pheochromocytoma group. Measurements of noradrenaline/normetanephrine levels were highest in the suspected pheocromocytoma group and lowest in the screening group. Hypertension was present in 63% of the incidentalomas, 79% of suspected pheochromocytomas and in none of the screening group. Paroxysmal symptoms were present in almost all with suspected pheochromocytoma while only in half of the other groups. The suspected pheocromocytoma group had most symptoms and the screening group least. The classic triad was present in 14% of the incidentalomas, in 28% of the suspected and in none of the screening group, while no symptoms at all was present in 12%, 0% and 25%, respectively. Pheochromocytoma crisis occurred in 5%. There was a positive correlation between tumor size vs hormone levels, and catecholamine levels vs blood pressure.
Clinicians need to be aware of the modern presentation of pheochromocytomas since early identification can be life-saving.
随着影像学检查的普及,在肾上腺偶发瘤的检查中诊断出的嗜铬细胞瘤越来越多。这可能改变了高血压这一经典表现以及头痛、出汗和心悸这一经典三联征的发生率。
我们回顾了94例连续的嗜铬细胞瘤病例。随后排除了2例异位促肾上腺皮质激素综合征病例。
在纳入的92例病例中,64%表现为偶发瘤,32%表现为疑似嗜铬细胞瘤,4%因先前诊断为MEN2A而接受筛查。接受筛查的患者最年轻,而表现为偶发瘤的患者最年长。女性在偶发瘤组和筛查组中更为常见,而男性在疑似嗜铬细胞瘤组中更为常见。去甲肾上腺素/去甲变肾上腺素水平的测量值在疑似嗜铬细胞瘤组中最高,在筛查组中最低。63%的偶发瘤患者、79%的疑似嗜铬细胞瘤患者存在高血压,而筛查组中无一例出现高血压。几乎所有疑似嗜铬细胞瘤患者都有阵发性症状,而其他组中只有一半患者有。疑似嗜铬细胞瘤组症状最多,筛查组最少。14%的偶发瘤患者、28%的疑似患者出现经典三联征,筛查组中无一例出现,而分别有12%、0%和25%的患者完全没有症状。5%的患者发生了嗜铬细胞瘤危象。肿瘤大小与激素水平、儿茶酚胺水平与血压之间存在正相关。
临床医生需要了解嗜铬细胞瘤的现代表现,因为早期识别可能挽救生命。